These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19937928)

  • 21. Aggregated IgG inhibits the differentiation of human fibrocytes.
    Pilling D; Tucker NM; Gomer RH
    J Leukoc Biol; 2006 Jun; 79(6):1242-51. PubMed ID: 16543402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief exposure to tryptase or thrombin potentiates fibrocyte differentiation in the presence of serum or serum amyloid p.
    White MJ; Galvis-Carvajal E; Gomer RH
    J Immunol; 2015 Jan; 194(1):142-50. PubMed ID: 25429068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.
    Wermuth PJ; Jimenez SA
    Clin Exp Immunol; 2014 Jan; 175(1):113-25. PubMed ID: 24111526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis.
    Attari H; Cao Y; Elmholdt TR; Zhao Y; Prince MR
    Radiology; 2019 Aug; 292(2):376-386. PubMed ID: 31264946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long pentraxin PTX3 promotes fibrocyte differentiation.
    Pilling D; Cox N; Vakil V; Verbeek JS; Gomer RH
    PLoS One; 2015; 10(3):e0119709. PubMed ID: 25774777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gadolinium-based contrast agent Omniscan® promotes in vitro fibroblast survival through in situ precipitation.
    Feng M; Fan YZ; Ma XJ; Li JX; Yang XG
    Metallomics; 2015 Jul; 7(7):1103-10. PubMed ID: 25867453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis.
    Chen W; Karhadkar TR; Ryu C; Herzog EL; Gomer RH
    Immunohorizons; 2020 Jun; 4(6):352-362. PubMed ID: 32576593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC; Abu-Alfa AK
    J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of fibrocyte differentiation by serum amyloid P.
    Pilling D; Buckley CD; Salmon M; Gomer RH
    J Immunol; 2003 Nov; 171(10):5537-46. PubMed ID: 14607961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model.
    Wagner B; Tan C; Barnes JL; Ahuja S; Davis TL; Gorin Y; Jimenez F
    Am J Pathol; 2012 Dec; 181(6):1941-52. PubMed ID: 23041060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D; Johnsen H; Juelsrud A; Løvhaug D
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 2 agonists inhibit human fibrocyte differentiation.
    Maharjan AS; Pilling D; Gomer RH
    Fibrogenesis Tissue Repair; 2010 Nov; 3():23. PubMed ID: 21106092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent.
    Bhagavathula N; DaSilva M; Aslam MN; Dame MK; Warner RL; Xu Y; Fisher GJ; Johnson KJ; Swartz R; Varani J
    Invest Radiol; 2009 Aug; 44(8):433-9. PubMed ID: 19561517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of phosphate on Omniscan(®) dechelation: an in vitro relaxivity study at pH 7.
    Robic C; Catoen S; De Goltstein MC; Idée JM; Port M
    Biometals; 2011 Aug; 24(4):759-68. PubMed ID: 21390525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients.
    Abujudeh HH; Rolls H; Kaewlai R; Agarwal S; Gebreananya ZA; Saini S; Schaefer PW; Kay J
    J Magn Reson Imaging; 2009 Dec; 30(6):1335-40. PubMed ID: 19937927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of gadolinium by dialysis: review of different strategies and techniques.
    Silberzweig JI; Chung M
    J Magn Reson Imaging; 2009 Dec; 30(6):1347-9. PubMed ID: 19937933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium contrast agent associated stimulation of human fibroblast collagen production.
    MacNeil S; Bains S; Johnson C; Idée JM; Factor C; Jestin G; Fretellier N; Morcos SK
    Invest Radiol; 2011 Nov; 46(11):711-7. PubMed ID: 21826007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.
    Idée JM; Fretellier N; Robic C; Corot C
    Crit Rev Toxicol; 2014 Nov; 44(10):895-913. PubMed ID: 25257840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.
    Endrikat J; Dohanish S; Schleyer N; Schwenke S; Agarwal S; Balzer T
    Invest Radiol; 2018 Sep; 53(9):541-550. PubMed ID: 29547493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.